PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-17.67%
Revenue decline while CRWV shows 23.55% growth. Joel Greenblatt would examine competitive position erosion.
-19.37%
Cost reduction while CRWV shows 19.16% growth. Joel Greenblatt would examine competitive advantage.
-17.12%
Gross profit decline while CRWV shows 25.15% growth. Joel Greenblatt would examine competitive position.
0.66%
Margin expansion 50-75% of CRWV's 1.30%. Martin Whitman would scrutinize competitive position.
3.84%
R&D change of 3.84% while CRWV maintains spending. Bruce Berkowitz would investigate effectiveness.
22.75%
G&A growth while CRWV reduces overhead. John Neff would investigate operational differences.
-11.29%
Marketing expense reduction while CRWV shows 248.84% growth. Joel Greenblatt would examine competitive risk.
No Data
No Data available this quarter, please select a different quarter.
-1.91%
Operating expenses reduction while CRWV shows 17.97% growth. Joel Greenblatt would examine advantage.
-9.07%
Total costs reduction while CRWV shows 18.28% growth. Joel Greenblatt would examine advantage.
16.67%
Interest expense growth above 1.5x CRWV's 1.19%. Michael Burry would check for over-leverage.
8.60%
D&A growth less than half of CRWV's 26.15%. David Dodd would verify if efficiency is sustainable.
-38.16%
EBITDA decline while CRWV shows 33.05% growth. Joel Greenblatt would examine position.
-17.80%
EBITDA margin decline while CRWV shows 7.69% growth. Joel Greenblatt would examine position.
-30.08%
Operating income decline while CRWV shows 169.93% growth. Joel Greenblatt would examine position.
-15.08%
Operating margin decline while CRWV shows 156.60% growth. Joel Greenblatt would examine position.
-4.82%
Both companies reducing other expenses. Martin Whitman would check industry patterns.
-29.09%
Pre-tax income decline while CRWV shows 9.63% growth. Joel Greenblatt would examine position.
-13.88%
Pre-tax margin decline while CRWV shows 26.86% growth. Joel Greenblatt would examine position.
-57.43%
Tax expense reduction while CRWV shows 3.78% growth. Joel Greenblatt would examine advantage.
-21.13%
Net income decline while CRWV shows 7.67% growth. Joel Greenblatt would examine position.
-4.21%
Net margin decline while CRWV shows 25.27% growth. Joel Greenblatt would examine position.
-20.51%
EPS decline while CRWV shows 23.08% growth. Joel Greenblatt would examine position.
-20.78%
Diluted EPS decline while CRWV shows 23.08% growth. Joel Greenblatt would examine position.
-0.91%
Share count reduction while CRWV shows 20.32% change. Joel Greenblatt would examine strategy.
-0.70%
Diluted share reduction while CRWV shows 20.32% change. Joel Greenblatt would examine strategy.